Physician

Michael James Glamore, M.D.

According to 2025 Medicare claims, Michael Glamore, M.D. (NPI: 1033522842) practices urology in the Santa Rosa-Petaluma, CA market, with the plurality of this provider's patient population coming from Sonoma, CA. This provider's primary affiliated billing organization is PROVIDENCE MEDICAL FOUNDATION (NPI: 1740584473; TIN: 330185031) and primary practice location at 95405-4570. Glamore is affiliated with the Health Connect Partners, LLC (ACO ID: A2342), participating under the MSSP model.

Glamore's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 793 traditional Medicare patients, billed 3,730 HCPCS/CPT codes, and received $377,282 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,551 prescription claims across 477 beneficiaries totaling $244,665 in drug costs, led by Gemtesa (Vibegron). DME data shows 130 claims. Open Payments data shows 43 records totaling $1,255. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $51,902 to $377,282. Similarly, Part D prescription costs have risen steadily, from $4,910 to $244,665. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	130	495	$51,902
2020	335	1,632	$128,607
2021	470	2,203	$232,854
2022	545	3,075	$274,249
2023	633	3,710	$295,601
2024	793	3,730	$377,282

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	81	146	$4,910
2016	47	82	$753
2017	57	90	$2,197
2018	11	28	$1,370
2019	48	105	$5,001
2020	140	446	$62,545
2021	233	912	$57,508
2022	314	1,024	$94,754
2023	382	1,327	$215,985
2024	477	1,551	$244,665

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	30	$18,433
2021	11	61	$35,237
2022	11	76	$40,513
2023	14	94	$52,877
2024	28	130	$76,507

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	163	163	$127
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	381	602	$99
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	380	504	$70
51798	Ultrasound measurement of bladder capacity after voiding	175	239	$10
81002	Urinalysis, manual test	228	286	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gemtesa	Vibegron	202	12,555	$193,815
Myrbetriq	Mirabegron	23	1,105	$17,661
Methenamine Hippurate	Methenamine Hippurate	64	3,705	$7,048
Tamsulosin Hcl	Tamsulosin Hcl	343	28,097	$4,808
Testosterone	Testosterone	22	645	$4,162

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	28	116	$73,099
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	14	$3,408

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	43	$1,255	Sumitomo Pharma America, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael James Glamore, M.D.?

Tedicare shows public-source Medicare data for Michael James Glamore, M.D. (NPI 1033522842), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael James Glamore, M.D. have ACO affiliation data?

Michael James Glamore, M.D. is shown with ACO affiliation data for Health Connect Partners, LLC (MSSP, ACO ID A2342).

What billing organization is linked to Michael James Glamore, M.D.?

Michael James Glamore, M.D. is linked to PROVIDENCE MEDICAL FOUNDATION (billing NPI 1740584473) in the available physician profile data.

Does Michael James Glamore, M.D. have Open Payments data?

Michael James Glamore, M.D. has 43 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.